These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25216549)

  • 21. TopBP1 contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53.
    Lv Y; Huo Y; Yu X; Liu R; Zhang S; Zheng X; Zhang X
    Drug Des Devel Ther; 2016; 10():3053-3064. PubMed ID: 27729767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
    Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
    Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1α-promoted glycolysis in non-small cell lung cancer cells.
    Jiang S; Wang R; Yan H; Jin L; Dou X; Chen D
    Mol Med Rep; 2016 May; 13(5):4101-7. PubMed ID: 27035555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-course analysis of DNA damage response-related genes after in vitro radiation in H460 and H1229 lung cancer cell lines.
    Kim KH; Yoo HY; Joo KM; Jung Y; Jin J; Kim Y; Yoon SJ; Choi SH; Seol HJ; Park WY; Nam DH
    Exp Mol Med; 2011 Jul; 43(7):419-26. PubMed ID: 21633183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer.
    Stella GM; Senetta R; Inghilleri S; Verdun di Cantogno L; Mantovani C; Piloni D; Scudeller L; Meloni F; Papotti M; Ricardi U; Cassoni P
    Neuro Oncol; 2016 Apr; 18(4):598-9. PubMed ID: 26905077
    [No Abstract]   [Full Text] [Related]  

  • 26. Surfactant Protein B Suppresses Lung Cancer Progression by Inhibiting Secretory Phospholipase A2 Activity and Arachidonic Acid Production.
    Lee S; Kim D; Kang J; Kim E; Kim W; Youn H; Youn B
    Cell Physiol Biochem; 2017; 42(4):1684-1700. PubMed ID: 28743125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global analysis of CpG methylation reveals epigenetic control of the radiosensitivity in lung cancer cell lines.
    Kim EH; Park AK; Dong SM; Ahn JH; Park WY
    Oncogene; 2010 Aug; 29(33):4725-31. PubMed ID: 20531302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of TopBP1 in hereditary breast cancer.
    Forma E; Krzeslak A; Bernaciak M; Romanowicz-Makowska H; Brys M
    Mol Biol Rep; 2012 Jul; 39(7):7795-804. PubMed ID: 22544570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIM1-activated PRAS40 regulates radioresistance in non-small cell lung cancer cells through interplay with FOXO3a, 14-3-3 and protein phosphatases.
    Kim W; Youn H; Seong KM; Yang HJ; Yun YJ; Kwon T; Kim YH; Lee JY; Jin YW; Youn B
    Radiat Res; 2011 Nov; 176(5):539-52. PubMed ID: 21910584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.
    Kang J; Kim E; Kim W; Seong KM; Youn H; Kim JW; Kim J; Youn B
    J Biol Chem; 2013 Sep; 288(38):27343-27357. PubMed ID: 23902763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
    Liu K; Graves JD; Lin FT; Lin WC
    J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solute carrier protein family may involve in radiation-induced radioresistance of non-small cell lung cancer.
    Xie L; Song X; Yu J; Guo W; Wei L; Liu Y; Wang X
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1739-47. PubMed ID: 21909646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARGC1A is upregulated and facilitates lung cancer metastasis.
    Li JD; Feng QC; Qi Y; Cui G; Zhao S
    Exp Cell Res; 2017 Oct; 359(2):356-360. PubMed ID: 28803067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis.
    Yu Z; Wang G; Zhang C; Liu Y; Chen W; Wang H; Liu H
    Cell Cycle; 2020 Feb; 19(3):300-316. PubMed ID: 31928130
    [No Abstract]   [Full Text] [Related]  

  • 38. TRIAP1 knockdown sensitizes non-small cell lung cancer to ionizing radiation by disrupting redox homeostasis.
    Hao CC; Luo JN; Xu CY; Zhao XY; Zhong ZB; Hu XN; Jin XM; Ge X
    Thorac Cancer; 2020 Apr; 11(4):1015-1025. PubMed ID: 32096592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rad9, Rad17, TopBP1 and claspin play essential roles in heat-induced activation of ATR kinase and heat tolerance.
    Tuul M; Kitao H; Iimori M; Matsuoka K; Kiyonari S; Saeki H; Oki E; Morita M; Maehara Y
    PLoS One; 2013; 8(2):e55361. PubMed ID: 23383325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
    Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
    Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.